2.84 USD
↗ 0.00 (0.18%)PRE MARKET (AS OF 04:03 AM EDT)
X4 Pharmaceuticals, Inc. Common Stock
XFORNASDAQ • USD
Market: OPEN
Shares of X4 Pharmaceuticals, Inc. Common Stock (XFOR) are trading at $2.84. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, XFOR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 2, 2026.
Open?$2.84
High?$2.84
Low?$2.84
Prev. Close?$2.83
Volume?70
Avg. Volume?1.0M
VWAP?$2.84
Rel. Volume?0.00x
Bid / Ask
Bid?$2.79 × 100
Ask?$2.90 × 100
Spread?$0.11
Midpoint?$2.84
Valuation & Ratios
Market Cap?280.6M
Shares Out?99.1M
Float?86.0M
Float %?86.8%
P/E Ratio?N/A
P/B Ratio?1.80
EPS?-$0.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Employees
45
Market Cap
280.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2017-11-16
Address
61 NORTH BEACON STREET
BOSTON, MA 02134
Phone: 857-529-8300
BOSTON, MA 02134
Phone: 857-529-8300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?97
Short Sent.?29
Piotroski F-Score?3/9Weak
Altman Z-Score?-1.90Distress
Confidence?51%Low
Short InterestHigh
Short % of Float?9.57%Elevated
Short Interest?8.2M
Days to Cover?7.1
Free Float86.0M
Avg Daily Volume1.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?11.30Strong
Quick Ratio?11.02Strong
Cash Ratio?10.07Strong
Debt/Equity?0.49Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.80CHEAP▾
Peers100
S&P80
P/S?17.71HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?10.24HIGH▾
Peers100
S&P10
Returns & Efficiency
ROE?-58.0%WEAK▾
S&P3
ROA?-35.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-83736000
Enterprise Value?$162.2M
Fundamentals ratios updated end of day